microarrays
PathogenDx Gets CE Mark for Microarray-Based COVID-19 Test
The test has also received Emergency Use Authorization from the US Food and Drug Administration and detects SARS-CoV-2 within three hours of RNA extraction.
Agilent, Oxford BioDynamics Sign Supply, Resale Agreement for Array Kit
Agilent will supply a custom-made SurePrint G3CGH Microarray for Oxford's newly launched Explorer Array Kit, which will include OBD's 3D Genome Probes.
FLEX will include full transcriptome data paired with 800 data points from 10,000 patients, offering researchers the chance to study diverse patient subsets.
PathoNext to Offer Agendia's Breast Cancer Recurrence Assays in Germany
PathoNext will run Agendia's assays in its labs using next-generation sequencing and work with HiSS, Agendia's German distributor, to offer the tests to German patients.
Agendia Adds to Data Supporting Breast Cancer Assay in Guiding Long-Term Endocrine Therapy Use
Premium
Recently presented data confirm prior findings that Agendia's MammaPrint may help doctors decide whether to limit tamoxifen treatment in certain patients.